NFE2L2 and neoplasm: When introduced, ZIF-8/SrSe@DOX markedly diminishes the expression of nuclear factor erythroid 2-related factor 2 (NRF2) and its associated protein p62, which facilitates the progression of ferroptosis in tumor cells.